Company’s smallest, most light-weight scanner receives approval.
Siemens Healthineers announced Tuesday it has received U.S. Food & Drug Administration approval for its 0.55T MAGENTOM Free.Max 80 cm MR Scanner.
This scanner is the company’s smallest and most lightweight, according to a company statement. As a High-V MR scanner, its 0.55T field strength combined with deep learning and advanced image processing not only make it useful across a wide range of clinical application, but as the first and only 80-cm bore, it can accommodate extremely obese or claustrophobic patients.
“Siemens Healthineers is proud to offer the MAGNETOM Free.Max, which brings MR to new clinical fields with innovative digital technology, new siting features, and image quality that was once realized only at higher field strengths,” said Jane Kilkenny, vice president of magnetic resonance at Siemens Healthineers North America. “The scanner’s comparatively low weight and size can open the door to MR utilization in orthopedic centers, emergency rooms, outpatient centers, and even intensive care units.”
The whole-body scanner itself weighs less than 3.5 tons, is less than 80 inches high, meaning it can be installed in areas that could not previously house a scanner with few structural modifications. Additionally, it uses less than 1 liter of helium with no need for a quench pipe for cooling.
According to company data, the scanner employs two image processing and artificial intelligence workflow innovations. Deep Resolve performs targeted de-noising and delivers higher-quality, higher-resolution images, and myExam Companion uses artificial intelligence to help users of all experience levels produce consistently high-quality images.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.